Dr. Tippi Mak started as a family physician from Canada, and has gained more than 15 years of medical, research, public health, policy, program, regulatory and corporate experience in vaccines and public health. For 5 years she was in hospital and clinical family practice, including specialised vaccination centres and international assignments. Through infectious disease field epidemiologic studies in low-resourced countries and numerous immunization-related activities with WHO over 9 years at global, regional and national levels in different country settings, she has gained an extensive understanding of the issues facing vaccines, from development, licensure, policy, public program implementation, surveillance, risk communication and evaluation. She was based in Switzerland 2006-2013, serving on WHO global advisories and two national vaccine policy advisory committees, as well as Assessor of the Swiss National Regulatory Authority, where she led the Swiss national pandemic influenza vaccine pharmacovigilance program and evaluation, among other responsibilities. In early 2014, she moved to Singapore and joined the Asia-Pacific regional office of the global vaccine company, Sanofi Pasteur, to lead the public policy efforts and regional stakeholder engagements in the launch of the first licensed dengue vaccine. Since Sept 2016, Dr. Mak now serves as Senior Deputy Director of Regional Health and Community Outreach for the Health Promotion Board, a national statutory board of the Ministry of Health, Singapore.
Dr. Mak holds a BSc (Psychology) and MD from the University of British Columbia, Canada, MSc (Public Health), London School of Hygiene & Tropical Medicine, and PhD in Epidemiology from the Swiss Tropical & Public Health Institute.